Abstract

BackgroundAbout one-third of the cervical cancer cases in Sweden occur in women over the age of 60. The primary aim of this study was to analyze the incidence of HPV, and HPV related dysplasia, in elderly women who had an HPV negative test at the age of 60 years or older.MethodsFrom October 2004 to June 2019, 1784 women aged 60–90 years were sampled for an HPV test when attending an outpatient gynecology clinic. Of these women, 827 HPV-negative women had two or more HPV tests at intervals of three months to eleven years (mean 3.2 years). The women with positive results had a repeat HPV test and cytology after 2.5 months on average. Those with a positive repeat HPV test were examined by colposcopy and biopsy.FindingsThe overall prevalence of HPV was 5.4%, (95%CI 4.4–6.6, 96/1784). The incidence of HPV in the 827 women, who were HPV negative in their first test, was 2.4% (95%CI 1.5–3.8, n = 20). At the repeat test 1.2% remained positive (95%CI 0.6–2.3, n = 10). HPV-related dysplasia diagnosed by histology was found in 1.2% (95%CI 0.6–2.3, n = 10) of the 827 women. CIN2+ was found in 0.5% (95%CI 0.2–1.3, n = 4). In the repeat HPV test 52.6% 10/19) were HPV positive. The time between an HPV negative test and an HPV positive test and CIN2+ was on average 45.5 months (range 10–85 months). The positive predictive value (PPV) for CIN2+ was 20.0% in the first positive HPV test and 40.0% in the repeat HPV test. The women with CIN2+ had normal cytology. No cancer or glandular dysplasia was detected.InterpretationIn this study older HPV-negative women were at risk of becoming HPV positive. Among the women who were HPV positive in a repeat test, there was a high risk of dysplasia.

Highlights

  • The incidence of cervical cancer (CC) in Sweden has increased over the past ten years despite a screening program with a coverage of more than 80% for the ages screened [1]

  • Women previously treated for cervical intraepithelial neoplasia grade 3 (CIN 3), are at increased risk of developing and dying from cervical or vaginal cancer, and the risk accelerates above 60 years of age [5]

  • The primary endpoint measurements were HPV infection in women with a negative HPV test at the age of 60 or older, HPV after repeat test and precursor lesions verified by cytology and histology

Read more

Summary

Introduction

The incidence of cervical cancer (CC) in Sweden has increased over the past ten years despite a screening program with a coverage of more than 80% for the ages screened [1]. Older women are not included in screening programs for cervical cancer. The part of Sweden where this study was performed introduced primary HPV screening up to the age of 64 in 2018. The average life expectancy for Swedish women has increased from 55 to 84 years [8]. About one-third of the cervical cancer cases in Sweden occur in women over the age of 60. The primary aim of this study was to analyze the incidence of HPV, and HPV related dysplasia, in elderly women who had an HPV negative test at the age of 60 years or older

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call